R
Robert J. Lefkowitz
Researcher at Howard Hughes Medical Institute
Publications - 867
Citations - 153371
Robert J. Lefkowitz is an academic researcher from Howard Hughes Medical Institute. The author has contributed to research in topics: Receptor & G protein-coupled receptor. The author has an hindex of 214, co-authored 860 publications receiving 147995 citations. Previous affiliations of Robert J. Lefkowitz include University of Nice Sophia Antipolis & University of Stuttgart.
Papers
More filters
Book ChapterDOI
Structure and Regulation of G Protein-Coupled Receptors: The β2-Adrenergic Receptor as a Model
TL;DR: This chapter discusses the major findings concerning the structure and coupling properties of G protein-coupled receptors and describes what is currently known about the pathways and mechanisms regulating trans-membrane signaling at the receptor level.
Journal ArticleDOI
[3H]WB4101--caution about its role as an alpha-adrenergic subtype selective radioligand.
TL;DR: It is found that both unlabeled and tritiated WB4101 bind with indistinguishable affinity to the alpha 1 and alpha 2 receptors in rabbit uterus, confirming thatWB4101 is alpha 1 selective in calf cerebral cortex.
Journal ArticleDOI
Catecholamine-induced desensitization of turkey erythrocyte adenylate cyclase. Structural alterations in the beta-adrenergic receptor revealed by photoaffinity labeling.
TL;DR: Data indicate that structural alterations in the beta-adrenergic receptor accompany the desensitization process in turkey erythrocytes, and this results in impaired ability of beta- adrenergic agonists to stimulate adenylate cycling in membranes prepared from these cells.
Journal ArticleDOI
Adenovirus-mediated gene transfer of the β2-adrenergic receptor to donor hearts enhances cardiac function
Alan P. Kypson,S. C. Hendrickson,Shahab A. Akhter,Katrina H. Wilson,Patricia McDonald,R. E. Lilly,Paul C. Dolber,Donald D. Glower,Robert J. Lefkowitz,Walter J. Koch +9 more
TL;DR: The results indicate that myocardial function of the transplanted heart can be enhanced by the adenovirus-mediated delivery of β2-ARs, and genetic manipulation may offer a novel therapeutic strategy to improve donor heart function in the post- operative setting.
Journal ArticleDOI
Conformationally selective RNA aptamers allosterically modulate the β2-adrenoceptor.
Alem W. Kahsai,James W. Wisler,Jungmin Lee,Jungmin Lee,Seungkirl Ahn,Thomas J. Cahill,S. Moses Dennison,Dean P. Staus,Alex R.B. Thomsen,Kara Anasti,Biswaranjan Pani,Laura M. Wingler,Hemant Desai,Kristin M. Bompiani,Kristin M. Bompiani,Ryan T. Strachan,Xiaoxia Qin,S. Munir Alam,Bruce A. Sullenger,Robert J. Lefkowitz,Robert J. Lefkowitz +20 more
TL;DR: Using biochemical, pharmacological, and biophysical approaches, it is demonstrated that RNA aptamers that bind a prototypical GPCR, β2-adrenoceptor (β2AR), bind with nanomolar affinity at defined surfaces of the receptor, allosterically stabilizing active, inactive, and ligand-specific receptor conformations.